Research map: Serum‐Proteomic Profiling Reveals Distinct Atopic Dermatitis Severity‐Linked Signatures
Back to the article
Papers in this map
- Feature Selection with the Boruta Package · Miron B. Kursa · 2010 · 5455 citations · Cited by this paper
- Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study) · 2026 · Related
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis · Julia Klein Gittler · 2012 · 988 citations · Cited by this paper
- Detergent‐Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans · 2026 · Related
- Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies · Ivette A.G. Deckers · 2012 · 560 citations · Cited by this paper
- Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk · 2026 · Related
- Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council · Yael Renert‐Yuval · 2021 · 352 citations · Cited by this paper
- Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children—An EAACI Scoping Review · 2026 · Related
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial · Emma Guttman‐Yassky · 2018 · 347 citations · Cited by this paper
- Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals · 2026 · Related
- Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial · Eric Lawrence Simpson · 2018 · 329 citations · Cited by this paper
- Artemisia annua Sublingual Immunotherapy Is Efficacious and Well Tolerated in Patients With Season Allergic Rhinitis: A Prospective, Open‐Label, Multicenter Phase IV Trial · 2026 · Related
- Variable selection and validation in multivariate modelling · Lin Shan Shi · 2018 · 219 citations · Cited by this paper
- The Airway Transcriptome in Type 2 Cytokine Biomarker‐High and ‐Low Severe Asthma · 2026 · Related
- β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin · Patrick A.M. Jansen · 2009 · 178 citations · Cited by this paper
- Maternal Perinatal Gut Microbiome Is Shaped by Traditional Farming Lifestyle and Associated With Early Childhood Atopic Disease · 2026 · Related
- The epithelial barrier theory and its associated diseases · Na Sun · 2024 · 167 citations · Cited by this paper
- Clinical Features of Cellular Senescence Pathways in Severe Asthma · 2026 · Related
- Association between Atopic Dermatitis and Depression in US Adults · Sherry H. Yu · 2015 · 165 citations · Cited by this paper
- Diet–Microbiome–Immune Interactions at the Gut Mucosa in Food Allergy: Mechanisms, Gaps, and Therapeutic Implications · 2026 · Related
- Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis · Carolyn M. Walsh · 2019 · 161 citations · Cited by this paper
- Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis · Benjamin Ungar · 2020 · 125 citations · Cited by this paper
- Oncostatin M can sensitize sensory neurons in inflammatory pruritus · Pang‐Yen Tseng · 2021 · 111 citations · Cited by this paper
- Increased serum human β-defensin-2 levels in atopic dermatitis: Relationship to IL-22 and oncostatin M · Naoko Kanda · 2011 · 67 citations · Cited by this paper
- Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis · Maja‐Lisa Clausen · 2013 · 61 citations · Cited by this paper
- Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis · Seung‐Ju Lee · 2021 · 46 citations · Cited by this paper
- Proteomic characterization of atopic dermatitis blood from infancy to adulthood · Ester DEL DUCA · 2023 · 38 citations · Cited by this paper
- TSLP and IL-7R Variants Are Associated with Persistent Atopic Dermatitis · Ronald Berna · 2020 · 28 citations · Cited by this paper
- Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry · Eric Lawrence Simpson · 2023 · 28 citations · Cited by this paper
- The ability of biomarkers to assess the severity of atopic dermatitis · Takeshi Nakahara · 2023 · 22 citations · Cited by this paper
- Role of Ezrin in Asthma-Related Airway Inflammation and Remodeling · Shu-Mei Zhao · 2022 · 10 citations · Cited by this paper
- IL-7 Deficiency Exacerbates Atopic Dermatitis in NC/Nga Mice · Hyun Jung Park · 2023 · 9 citations · Cited by this paper
- HPAStainR: a Bioconductor and Shiny app to query protein expression patterns in the Human Protein Atlas · Tim O. Nieuwenhuis · 2020 · 7 citations · Cited by this paper
- Serum β-Defensin 2, A Novel Biomarker for the Diagnosis of Acute Infections · John G. Routsias · 2023 · 7 citations · Cited by this paper
- Integrated bioinformatics-based identification of potential diagnostic biomarkers associated with atopic dermatitis · Guanghua Chen · 2022 · 6 citations · Cited by this paper
- Circulating Beta-Defensin 2 Levels Correlate with Conventional Inflammatory Markers in Infection-Free Individuals with Overweight and Obesity: An Exploratory Study · Theocharis Koufakis · 2025 · 4 citations · Cited by this paper
- 221 Bempikibart, a Novel Human IL-7Rα Antagonist Inhibiting IL-7 and TSLP Signaling, Demonstrated Robust Impact on T-cell Maintenance and Th2 Responses in T-cell Driven Skin Disease · C Galand · 2025 · 1 citation · Cited by this paper
Source: OpenAlex (CC0)